https://www.patsnap.com/resources/blog/rd-blog/continuous-glucose-monitor-wireless-telemetry-patent-landscape-patent-landscape/ · Patsnap · data cut-off 2026-08-31 · downloaded from the live page
Patent Landscape · Medical Devices & Implants
Continuous glucose monitor wireless telemetry patents: who holds the ground

A patent landscape analysis of continuous glucose monitor wireless telemetry: filing trends, assignee concentration, IPC technology composition and the most-cited records through 2026.

110
Published Records
69%
Top-5 Share of All Records
US
Leading Jurisdiction
46
Active Filers Ranked

Top-5 share = the 5 largest assignees ÷ all 110 records in scope (CR5), not the ranked leaders only.

Check your own idea
Published byPatsnap Research··6 min readSourced from Patsnap Eureka
Landscape Overview

What this patent landscape covers

This landscape covers 110 published records at the intersection of continuous glucose monitoring and wireless telemetry, filed between 2015 and the 2026-08-31 data cut-off. The scope is defined by IPC classes spanning diagnostic devices, body-fluid devices, neural stimulation, and wireless and data-processing networks, which means the dataset captures both the sensing side of continuous glucose monitors and the data-transport layer that carries readings off the device. Patent families, not raw document counts, are the fairer unit for reading concentration, and the assignee ranking here is built on that basis.

The representative filing below, from Dexcom and dated 2016, illustrates a recurring claim pattern in the corpus: limiting and authenticating which display devices a glucose transmitter will connect to. It sits alongside a small set of heavily cited foundational records that most later filers had to draft around.

Filing footprint by receiving office
  1. 1DEXCOM INC28
  2. 2BECTON DICKINSON & CO20
  3. 3DEKA PRODUCTS LP19
  4. 4ASCENSIA DIABETES CARE HLDG AG5
  5. 5ROCHE DIABETES CARE INC4
  6. 6STEVEN REID3
  7. 7THERASENSE INC3
  8. 8GOPALAKRISHNAN MURALIDHARAN3
  9. 9F HOFFMANN LA ROCHE & CO AG3
  10. 10INSULET CORP3
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Let an AI agent run this analysis on your own technology

Pick a task. Every answer cites the patents behind it.

10,000 free credits to start
Filing Data

Filing trends and technology composition

The 110 records in scope span 2015 through the current data cut-off, with publication lag meaning the most recent year understates real filing activity.

Filing activity by year

Filings rose from 2 in 2017 to a peak of 12 in 2020, and the partial 2026 figure reflects publication lag rather than a real slowdown; a growth rate is not stated here because fewer than four complete years remain once that lag is accounted for.

Filing activity by year03691222017201820191220202021202220232024202512026Most recent year is partial — publication lag means later filings are not yet visible.

Technology composition by IPC subclass

A61B diagnosis-and-surgery classes appear on 68.2% of the 110 records, ahead of G16H healthcare informatics at 49.1% and A61M body-fluid devices at 38.2%; because a record can carry several IPC classes these shares add to more than 100%, and the wireless-network class H04W proper sits at 15.5%, the clearest sign that most protection covers sensing and data handling rather than the radio link itself.

Technology composition by IPC subclassA61B · Diagnosis & surgery7568.2%G16H · Healthcare informatics5449.1%A61M · Devices for body fluids4238.2%G06F · Electric digital data processi…3632.7%H04W · Wireless communication networks1715.5%G06T · Image data processing & genera…1412.7%G01N · Material analysis & testing87.3%G06K · Data recognition & presentation76.4%Other5852.7%

Shares are the percentage of the 110 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Continuous Glucose Monitor Wireless Telemetry Patent Landscape with Eureka

This page is one run against one query. Ask Eureka your own question about continuous glucose monitor wireless telemetry patent landscape and every answer comes back with the patent numbers behind it.

Try Eureka
Representative Filing

Key patents shaping the field

Representative Record
CA2962650A12016-07-28

Continuous glucose monitor communication with multiple display devices

DEXCOM, INC.

The present disclosure relates to a continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays. Systems and methods are disclosed for limiting the number of display devices that can connect to a continuous glucose transmitter. Security, including hashing techniques and a changing application key, is used to provide secure communications between the continuous glucose transmitter and the displays, along with techniques for authenticating multiple displays and coordinating commands and data updates.Filed by Dexcom, Inc. in 2016 — illustrates the multi-display authentication pattern that recurs across the wider corpus.

View full record in Eureka
Most-cited records in scope
#Publication no.Patent titleCitations
1EP0880936A2Monitoring physical condition of a patient by telemetry929
2US20190252079A1System and method for decision support171
3US20160074587A1System and method for capturing dose information131
4US20170286638A1System and method for capturing dose information124
5WO2009016638A1Device for facilitating infusion of therapeutic fluids and sensing of bodily analytes123
6US20140313052A1Near Field Telemetry Link for Passing a Shared Secret to Establish a Secure Radio Frequency Communication Lin…101
7US20140066735A1Diabetes manager for glucose testing and continuous glucose monitoring101
8US20120259389A1Treatment of postprandial hyperglycemia by gastric electrical stimulation66
9WO2005101994A2Method and apparatus for providing sensor guard for data monitoring and detection systems62
10US9636457B2System and method for a drug delivery and biosensor patch46

Citation counts are drawn from a searched corpus and favour older filings; treat them as a measure of influence on later drafting, not of current commercial importance.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Signal Check

What the numbers mean for a filing decision

These four cards translate the raw filing and citation data into the questions a competitive-intelligence or IP team actually needs answered before choosing where to file next.

Concentration
69.1%
of 110 records held by top 5

A small group holds most of the ground

With the top five assignees controlling 69.1% of all 110 records and the top ten controlling 82.7%, most competitive risk in this field comes from a handful of large portfolios. The remaining 36 ranked companies each hold small numbers of records, forming a long tail rather than a second tier of comparable size.

Assignee ranking, 46 companies
Technology Mix
68.2% vs 15.5%
A61B share vs H04W share

Sensing claims dominate, not the radio link

A61B diagnosis-and-surgery classes appear on 68.2% of the 110 records; H04W wireless-network classes appear on only 15.5%. The wireless transport layer looks comparatively open compared with sensor and data-handling claims, though any new filing there should still be checked against this smaller but real prior-art base.

IPC composition, all 110 records
Citation Signal
929 citations
EP0880936A2, most-cited record

One foundational document anchors the field

EP0880936A2, on telemetric monitoring of a patient's physical condition, carries far more citations than any other record in the corpus. High citation counts inside a searched corpus favour older filings, so this signals historical influence and a document every later filer had to draft around, not necessarily current commercial weight.

Most-cited records table
Filing Cadence
12 filings
peak year, 2020

Recent years understate real activity

Filing rose from 2 records in 2017 to a peak of 12 in 2020. Because publication lags filing by roughly 18 months, the partial 2026 figure of 1 record should not be read as a slowdown — a growth rate is intentionally not stated here given fewer than four complete years remain once lag is factored in.

Filing trend, 2017–2026
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to continuous glucose monitor wireless telemetry patent landscape, with the prior art for and against each one.

Find the white space →
Where joint filing shows up
AssigneeCo-assigneeShared families
Medingo Ltd.F. Hoffmann-La Roche Ltd.1
Medingo Ltd.YODFAT OFER1
Medingo Ltd.GESCHEIT ILLAI1
Medingo Ltd.CHEIT IDDO M1
THERASENSE INCREGGIARDO CHRISTOPHER V1

Only five co-assignee pairs appear across the dataset, indicating that most protection in this field is held and defended by single entities rather than through joint development arrangements.

Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Next Steps

Where to take this analysis next

The figures above establish concentration and technology mix; the next questions are about specific claims, specific competitors, and specific gaps.

Check freedom-to-operate against the leading portfolios

With 69.1% of the 110 records held by the top five assignees, a new filing or product in multi-display CGM telemetry should be checked claim-by-claim against those portfolios before design work goes further.

Run a freedom-to-operate check in Eureka

Map the under-claimed branches in detail

G01N and G06K sit far below the density of A61B and G16H — worth a closer look before assuming the sensing and informatics space is fully closed off.

Explore white space in Eureka

Track the assignee ranking as new filings publish

With only 1 record published so far in 2026 against a 2020 peak of 12, watching how the ranking shifts as lagged filings surface will matter more than reading the current year in isolation.

Set up tracking in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Frequently Asked

Questions practitioners ask about this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Continuous Glucose Monitor Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Continuous Glucose Monitor Wireless Telemetry Patent Landscape in depth with Eureka

Go past this page: query the whole continuous glucose monitor wireless telemetry patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.